VIVEbiotech has received the "Business Innovation" award at the XXXII edition of the Basqu... 24/10/2023 Healthcare Innovative drugs Personalized medicine Advanced therapies VIVEbiotech has received the "Innovacion Empresarial/Business Innovation" award at the XXXII edition of the La Noche de... Partners - VIVEbiotech
A4CELL Celebrates a Remarkable Year with €3 MillionInvestment to Transform Living Single C... 19/10/2023 Healthcare Advanced therapies Financing This momentousinvestment will serve as the catalyst for revolutionizing the landscape of living single cellanalysis. Partners
SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting... 17/10/2023 Healthcare Drug discovery Rare diseases Advanced therapies Spark secures exclusive worldwide rights to SpliceBio’s proprietary Protein Splicing platform to develop, manufacture... Partners - Asabys Partners
Training course on Advanced Therapy Medicinal Products (ATMPs) Online Del 14/11/2023 09:00 to 14/11/2023 16:00 Healthcare This course will review the role and evolution of the most relevant Regulatory Agencies, the different procedures and...
The Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park 24/08/2023 Healthcare Innovative drugs Advanced therapies The company specialises in the development of molecules for oncological and gastrointestinal immunological treatments... Partners - Parc Científic de Barcelona
VIVEbiotech participates in the European MAGIC project 11/07/2023 Healthcare Personalized medicine Advanced therapies Gene editing International EU projects Financing VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is... Partners - VIVEbiotech
The use of cell secretomes opens a new era of advanced therapies 07/07/2023 Drug discovery Innovative drugs Personalized medicine Advanced therapies The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM) celebrating its 1st... Partners - PEACHES BIOTECH S.L.
Biotech companies’ R&D investment grows by 16% in 2022 to reach €1,038 million 20/06/2023 Healthcare Advanced therapies Agrifood Financing In 2021, the impact on GDP of biotech companies amounted to €11,183 million, or 1% of GDP AseBio
ZIP Solutions and YIMA Announce Strategic Co-Marketing Agreement for Gene Therapy 05/06/2023 Healthcare Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies International ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI-enabled biotech... Partners - Biotechnology Assets
AseBio presents the ‘Map of advanced-therapy capacities of the biotech industry’ in Spain 23/05/2023 Healthcare Innovative drugs Advanced therapies Over 30 innovative biotech companies possess the comprehensive capabilities to develop advanced therapies, from initial... AseBio
